Expression of extracellular superoxide dismutase during adipose differentiation in 3T3-L1 cells

Redox Report

Volumn 14, Issue 1, 2009, Pages 34-40

  Adachi, Tetsuo ^a   Toishi, Taisuke ^a   Wu, Haoshu ^a,b   Kamiya, Tetsuro ^a   Hara, Horokazu ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

3T3 L1 cells; Adipose differentiation; Extracellular superoxide dismutase

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; LIPOPOLYSACCHARIDE; MESSENGER RNA;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL STIMULATION; CELL STRAIN 3T3; COCULTURE; DOWN REGULATION; EXTRACELLULAR MATRIX; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; UPREGULATION; ANIMAL; CELL LINE; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME;

MUS;

3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; ANIMALS; CELL DIFFERENTIATION; CELL LINE; CHEMOKINE CCL2; COCULTURE TECHNIQUES; GENE EXPRESSION; GENE EXPRESSION PROFILING; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPEROXIDE DISMUTASE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 62449132773     PISSN: 13510002     EISSN: None     Source Type: Journal    
DOI: 10.1179/135100009X392467     Document Type: Article

References (32)

1. Eriksson JW. Metabolic stress in insulin's target cells leads to ROS accumulation: A hypothetical common pathway causing insulin resistance. FEBS Lett 2007; 581: 3734-3742.
2. Havel PJ. Update on adipocyte hormones: Regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 2004; 53 (Suppl 1): S143-S151.
3. Furukawa S, Fujita T, Shimabukuro M et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752-1761.
4. Roberts CK, Barnard RJ, Sindhu RK, Jurczak M, Ehdaie A, Vaziri ND. Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome. Metabolism 2006; 55: 928-934.
5. Marklund SL. Human copper-containing superoxide dismutase of high molecular weight. Proc Natl Acad Sci USA 1982; 79: 7634-7638.
6. Marklund SL. Extracellular superoxide dismutase in human tissues and human cell lines. J Clin Invest 1984; 74: 1398-1403.
7. Ookawara T, Imazeki N, Matsubara O et al. Tissue distribution of immunoreactive mouse extracellular superoxide dismutase. Am J Physiol 1998; 275: C840-C847.
8. Adachi T, Inoue M, Hara H, Maehata E, Suzuki S. Relationship of plasma extracellular-superoxide dismutase level with insulin resistance in type 2 diabetic patients. J Endocrinol 2004; 181: 413-417.
9. Davis KE, Moldes M, Farmer SR. The forkhead transcription factor FoxC2 inhibits white adipocyte differentiation. J Biol Chem 2004; 279: 42453-42461.
10. Mori T, Sakaue H, Iguchi H et al. Role of Krüppel-like factor 15 (KLF15) in transcriptional regulation of adipogenesis. J Biol Chem 2005; 280: 12867-12875.
11. Sakaue H, Konishi M, Ogawa W et al. Requirement of fibroblast growth factor 10 in development of white adipose tissue. Genes Dev 2002; 16: 908-912.
12. Adachi T, Inoue M, Hara H, Suzuki S. Effects of PPARγ ligands and C/EBPβ enhancer on expression of extracellular-superoxide dismutase. Redox Report 2004; 9: 207-212.
13. Fox KE, Fankell DM, Erickson PF, Majka SM, Crossno Jr JT, Klemm DJ. Depletion of cAMP-response element-binding protein/ATF1 inhibits adipogenic conversion of 3T3-L1 cells ectopically expressing CCAAT/ enhancer-binding protein (C/EBP)α, C/EBPβ, or PPARγ2. J Biol Chem 2006; 281: 40341-40353.
14. Fasshauer M, Klein J, Kralisch S et al. Monocyte chemoattractant protein 1 expression is stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2004; 317: 598-604.
15. Charo IF, Taubman MB. Chemokines in the pathogenesis of vascular disease. Circ Res 2004; 95: 858-866.
16. Marklund SL. Regulation by cytokines of extracellular superoxide dismutase and other superoxide dismutase isoenzymes in fibroblasts. J Biol Chem 1992; 267: 6696-6701.
17. Strålin P, Marklund SL. Multiple cytokines regulate the expression of extracellular superoxide dismutase in human vascular smooth muscle cells. Atherosclerosis 2000; 151: 433-441.
18. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction? Diabetes 2003; 52: 1-8.
19. Carvalho-Filho MA, Ueno M, Hirabara SM et al. S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/ Akt: A novel mechanism of insulin resistance. Diabetes 2005; 54: 959-967.
20. Strålin P, Karlsson K, Johansson BO, Marklund SL. The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol 1995; 15: 2032-2036.
21. Marklund SL. Expression of extracellular superoxide dismutase by human cell lines. Biochem J 1990; 266: 213-219.
22. Takatsu H, Tasaki H, Kim HN et al. Overexpression of EC-SOD suppresses endothelial-cell-mediated LDL oxidation. Biochem Biophys Res Commun 2001; 285: 84-91.
23. Heistad DD. Oxidative stress and vascular disease: 2005 Duff lecture. Arterioscler Thromb Vasc Biol 2006; 26: 689-695.
24. Strålin P, Marklund SL. Vasoactive factors and growth factors alter vascular smooth muscle cell EC-SOD expression. Am J Physiol 2001; 281: H1621-H1629.
25. Adachi T, Hara H, Yamada H et al. Heparin-stimulated expression of extracellular-superoxide dismutase in human fibroblasts. Atherosclerosis 2001; 159: 307-312.
26. Adachi T, Toishi T, Takashima E, Hara H. Infliximab neutralizes the suppressive effect of TNF-α on expression of extracellular-superoxide dismutase in vitro. Biol Pharm Bull 2006; 29: 2095-2098.
27. Suganami T, Nishida J, Ogawa Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: Role of free fatty acids and tumor necrosis factor α. Arterioscler Thromb Vasc Biol 2005; 25: 2062-2068.
28. Neels JG, Pandey M, Hotamisligil GS, Samad F. Autoamplification of tumor necrosis factor-α. Am J Pathol 2006; 168: 435-444
29. Cawthorn WP, Sethi JK. TNF-α and adipocyte biology. FEBS Lett 2008; 582 b: 117-131.
30. Souza SC, Palmer HJ, Kang YH et al. TNF-α induction of lipolysis is mediated through activation of the extracellular signal related kinase pathway in 3T3-L1 adipocytes. J Cell Biochem 2003; 89: 1077-1086.
31. Reilly PM, Schiller HJ, Bulkley GB. Pharmacologic approach to tissue injury mediated by free radicals and other reactive oxygen metabolites. Am J Surg 1991; 161: 488-503.
32. Laukkanen MO, Lehtolainen P, Turunen P et al. Rabbit extracellular superoxide dismutase: Expression and effect on LDL oxidation. Gene 2000; 254: 173-179.